SES - Delayed Quote USD

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

Compare
2.0400
-0.0500
(-2.39%)
At close: January 10 at 4:58:45 PM GMT+8

Research Analysis

Revenue vs. Earnings

Revenue 1.62B
Earnings --
Q3'14
Q4'14
Q1'15
0
500M
1B
2B
2B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----22
Avg. Estimate ----8.72B9.54B
Low Estimate ----8.5B9.37B
High Estimate ----8.95B9.72B
Year Ago Sales ----8.22B8.72B
Sales Growth (year/est) ----6.11%9.39%

EPS Trend

Currency in USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
T14.SI --------
S&P 500 8.70%11.55%14.03%13.42%